99 related articles for article (PubMed ID: 8317363)
1. [HTLV-I and ocular disease].
Ohba N; Nakao K
Nippon Ganka Gakkai Zasshi; 1993 Apr; 97(4):433-40. PubMed ID: 8317363
[TBL] [Abstract][Full Text] [Related]
2. Systemic diseases in patients with HTLV-1-associated uveitis.
Nakao K; Abematsu N; Sakamoto T
Br J Ophthalmol; 2018 Mar; 102(3):373-376. PubMed ID: 28689168
[TBL] [Abstract][Full Text] [Related]
3. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
4. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
5. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
6. Ocular manifestations in patients infected with human T-lymphotropic virus type I.
Ohba N; Matsumoto M; Sameshima M; Kabayama Y; Nakao K; Unoki K; Uehara F; Kawano K; Maruyama I; Osame M
Jpn J Ophthalmol; 1989; 33(1):1-12. PubMed ID: 2733251
[TBL] [Abstract][Full Text] [Related]
7. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
8. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
9. [Intraocular inflammation and homeostasis of the eye].
Mochizuki M
Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
[TBL] [Abstract][Full Text] [Related]
10. [HTLV-I associated retinochoroidal degeneration].
Nakao K; Ohba N; Isashiki Y
Nippon Ganka Gakkai Zasshi; 1995 Aug; 99(8):910-3. PubMed ID: 7676890
[TBL] [Abstract][Full Text] [Related]
11. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
12. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
[TBL] [Abstract][Full Text] [Related]
13. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
14. Human T-lymphotropic virus type I uveitis.
Yamaguchi K; Mochizuki M; Watanabe T; Miyata N; Tajima K; Mori S; Takatsuki K
Leukemia; 1994 Apr; 8 Suppl 1():S88-90. PubMed ID: 8152312
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of HTLV-I associated uveitis determined in multicenter collaborative study. Study Group for HTLV-I Associated Ocular Diseases.
Ohba N; Nakao K; Isashiki Y; Kaminagayoshi T; Sonoda S; Yashiki S; Osame M
Jpn J Ophthalmol; 1994; 38(2):168-74. PubMed ID: 7967208
[TBL] [Abstract][Full Text] [Related]
16. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM
J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786
[TBL] [Abstract][Full Text] [Related]
17. The HTLV-1 neurological complex.
Araujo AQ; Silva MT
Lancet Neurol; 2006 Dec; 5(12):1068-76. PubMed ID: 17110288
[TBL] [Abstract][Full Text] [Related]
18. Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I.
Nakao K; Ohba N; Matsumoto M
Jpn J Ophthalmol; 1989; 33(4):472-81. PubMed ID: 2576286
[TBL] [Abstract][Full Text] [Related]
19. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
